Ferric Carboxymaltose in HF with Iron Deficiency | NEJM
Автор: NEJM Group
Загружено: 2023-09-14
Просмотров: 19213
In patients with heart failure, a reduced ejection fraction, and iron deficiency, intravenous ferric carboxymaltose improves quality of life and functional capacity; clinical outcomes are unclear.
New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/44rzIe4
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: